You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

21 December 2016

Experimental PrEP drug injected once every two months to begin global trial

Adherence challenges with pre-exposure prophylaxis (PrEP) could be overcome if experimental long-acting HIV drug is found to be effective and acceptable.

0
30 November 2016

Holding our hands up for prevention

As we mark the 29th World AIDS Day, Sarah Hand says that with enough commitment, political will and funding we have the tools to achieve UNAIDS’ ambitious fast track targets – but only if we recognise the need for a new approach to HIV prevention.

0
23 November 2016

Global ‘War on Drugs’ has failed and exacerbated the HIV epidemic, say global experts

Drug policy based on prohibition hasn't worked. It's time to build on the success of partial-decriminalisation models with an emphasis on health and human rights, says new report.

0
14 November 2016

Norway provides PrEP for free to all those at risk of HIV

The game-changing drug, Truvada – the only drug approved for PrEP – will be offered to groups considered at risk of HIV.

0
11 November 2016

Five things everyone should know about HIV

We count down the top five things that everybody should know about HIV - from AIDS, to testing, to symptoms, to treatment.

0
25 October 2016

Understanding the barriers to circumcision in southern and eastern Africa

Despite a willingness of men to undergo voluntary medical male circumcision (VMMC) for HIV prevention benefits in sub-Saharan Africa, uptake is low with just 56% of the 20.8 million circumcisions by 2016 target met.

0
14 September 2016

Europe grants marketing approval of Truvada for use as PrEP

The European Commission has given pharmaceutical company, Gilead, the green light to market Truvada as pre-exposure prophylaxis (PrEP) across the region.

0
02 September 2016

Vaginal ring for HIV prevention effective and acceptable

An updated adherence analysis from the ASPIRE study indicates that consistent users of a vaginal ring containing dapivirine experienced 65% fewer infections, the 21st International AIDS Conference in Durban, South Africa heard last month.

0
16 August 2016

WHO to convene expert review on hormonal contraceptives

Heightened concerns regarding the link between the hormonal contraceptive, Depo-Provera, and the risk of HIV acquisition in women after new systematic review released.

0